Opportunity Information: Apply for ONDCP DEW 2017
The Drug Early Warning Signals from High Risk Populations opportunity (ONDCP DEW 2017) is a discretionary, science and technology/research-focused cooperative agreement offered by the Office of National Drug Control Policy (ONDCP) within the Executive Office of the President. Its central goal is to strengthen and expand a practical early warning approach for detecting emerging and changing drug use trends by re-testing urine specimens that have already been collected and analyzed under routine drug testing protocols. Instead of paying for new specimen collection, the project re-uses previously gathered samples before they are discarded, which is meant to deliver a faster, lower-cost snapshot of what drugs are actually showing up in specific high-risk populations and local areas.
The project builds on methodology first developed through criminal justice settings, including individuals in pre-trial or lock-up environments, people on parole or probation, and drug court participants. Early testing in healthcare settings (specifically trauma units and more recently emergency department populations) showed promising results, so the grant is aimed at extending this same framework into additional venues where biological samples are commonly collected. These settings can include opioid treatment admissions, trauma units or emergency departments, and community corrections programs. The key idea is to compare what conventional, standard panels detect versus what a much broader analytical screen reveals, especially in a market where synthetic opioids and other novel substances can appear quickly and vary substantially by region.
A major feature of the approach is expanded laboratory analysis. Existing urine samples are to be sampled and re-tested using a government laboratory capable of screening for more than 150 substances, at no cost for the lab testing itself. The recipient is expected to focus resources on the research, analysis, and interpretation of the re-test results and to translate those findings into usable early warning indicators for drug policy and prevention planning. This includes identifying which "old" drugs remain prevalent, which new drugs are emerging, and which substances are routinely missed by conventional testing protocols. The opportunity explicitly highlights fentanyl and its analogues as examples of drugs that may be present even when individuals believe they used something else, underscoring the value of biological confirmation over self-report alone.
The awardee will work in close coordination with ONDCP (consistent with the cooperative agreement structure) to refine the expanded testing panel, including deciding which metabolites to include beyond the traditional NIDA-5 set, with particular attention to synthetic cannabinoids and synthetic opioids. In addition to technical input on the testing panel, the recipient must establish working relationships and data-sharing pipelines with partner organizations that can supply specimens suitable for re-testing, spanning criminal justice, healthcare, and treatment contexts. The outcome ONDCP is seeking is an actionable, geographically and demographically sensitive picture of drug exposure patterns across subpopulations, produced quickly enough to support real-time policy awareness and response.
Administrative details reflect a single, relatively small award intended to support analysis rather than expensive field collection or laboratory buildout. The expected number of awards is one, with an award ceiling of $100,000. Eligible applicants are public and state-controlled institutions of higher education (and the narrative description also indicates public nonprofit institutions/organizations such as hospitals are within the intended applicant pool). The CFDA number is 95.007. ONDCP anticipated continuing to use the Armed Forces Medical Examiner System for laboratory testing services at no charge, further emphasizing that the grant dollars are meant to pay for coordination, analytic work, and interpretation rather than the core lab testing itself.Apply for ONDCP DEW 2017
- The Office of National Drug Control Policy in the science and technology and other research and development sector is offering a public funding opportunity titled "Drug Early Warning Signals from High Risk Populations" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 95.007.
- This funding opportunity was created on Sep 01, 2017.
- Applicants must submit their applications by Sep 11, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $100,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Public and State controlled institutions of higher education.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the ONDCP DEW 2017 opportunity?
ONDCP DEW 2017 (Drug Early Warning Signals from High Risk Populations) is a discretionary, science and technology/research-focused cooperative agreement offered by the Office of National Drug Control Policy (ONDCP) within the Executive Office of the President. The project is designed to strengthen and expand an early warning approach for detecting emerging and changing drug use trends using biological confirmation from urine testing.
What is the main goal of this project?
The central goal is to generate practical early warning indicators of drug exposure by re-testing urine specimens that were already collected and initially analyzed under routine drug testing protocols. The intent is to detect shifts in drug markets and identify substances that conventional testing may miss, quickly enough to inform policy and prevention planning.
How does this approach differ from typical drug trend monitoring?
Instead of funding new specimen collection, the project re-uses previously gathered urine samples before they are discarded. This is intended to provide a faster, lower-cost snapshot of what drugs are actually present in specific high-risk populations and local areas, based on lab findings rather than self-report alone.
What types of specimens are used for the project?
The project uses urine specimens that have already been collected for routine testing in partner settings. The key feature is that these are existing samples that would otherwise be discarded after routine analysis.
What populations and settings does the methodology build on?
The approach builds on methodology first developed in criminal justice settings, including individuals in pre-trial or lock-up environments, people on parole or probation, and drug court participants.
Which additional settings may be included under this grant?
The opportunity is aimed at extending the framework into additional venues where biological samples are commonly collected. Examples mentioned include opioid treatment admissions, trauma units or emergency departments, and community corrections programs.
Why is expanded laboratory testing emphasized?
A key objective is to compare what conventional, standard testing panels detect versus what a much broader analytical screen reveals. This is especially important in environments where synthetic opioids and other novel substances can emerge quickly and vary substantially by region.
How broad is the expanded drug screen?
The expanded screening is described as capable of detecting more than 150 substances through a government laboratory, which is far broader than typical routine panels.
Who pays for the expanded laboratory testing?
The expanded laboratory analysis is to be performed by a government laboratory at no cost for the lab testing itself. The opportunity notes that ONDCP anticipated continuing to use the Armed Forces Medical Examiner System for these laboratory testing services at no charge.
What is the role of the grant recipient if lab testing is provided at no cost?
The recipient is expected to focus resources on research activities such as coordination with specimen-supplying partners, analysis of the re-test results, interpretation of findings, and translating results into usable early warning indicators for drug policy and prevention planning.
What types of findings is ONDCP looking for?
The project is intended to identify which established ("old") drugs remain prevalent, which new drugs are emerging, and which substances are routinely missed by conventional testing protocols. The desired outcome is an actionable picture of drug exposure patterns that is sensitive to geography and demographic subpopulations.
Why does the opportunity mention fentanyl and its analogues?
The opportunity highlights fentanyl and its analogues as examples of substances that may be present even when individuals believe they used something else. This underscores the value of biological confirmation and broad screening for detecting hidden or unexpected drug exposures.
What is meant by comparing conventional panels to expanded testing?
It refers to contrasting what routine, standard drug testing panels identify with what a much broader re-test panel detects. This comparison can reveal gaps in conventional protocols and point to substances that may be circulating in local markets but not routinely tested for.
What is the NIDA-5 set, and how does it relate to this project?
The opportunity references expanding beyond the traditional NIDA-5 set by refining which additional metabolites to include in the expanded testing panel. The focus is on determining what should be added beyond standard testing to better capture emerging substances.
Which drug categories receive special attention in the expanded panel?
The opportunity calls for particular attention to synthetic cannabinoids and synthetic opioids when refining the expanded testing panel and selecting metabolites beyond traditional testing sets.
What does "cooperative agreement" mean for this award?
The award is structured as a cooperative agreement, and the recipient is expected to work in close coordination with ONDCP. This includes collaboration to refine the expanded testing panel and align the project with ONDCP objectives.
What partnerships are expected as part of the project?
The recipient must establish working relationships and data-sharing pipelines with partner organizations that can supply specimens suitable for re-testing. Partners may span criminal justice, healthcare, and treatment contexts.
What kinds of data outputs is ONDCP seeking?
ONDCP is seeking early warning indicators that are actionable and can support real-time policy awareness and response. The outputs should describe drug exposure patterns across subpopulations and local areas in a way that is useful for drug policy and prevention planning.
How many awards are expected under this opportunity?
The expected number of awards is one.
What is the maximum funding amount for this award?
The award ceiling is $100,000.
What is the CFDA number for this opportunity?
The CFDA number is 95.007.
Who is eligible to apply?
Eligible applicants are public and state-controlled institutions of higher education. The narrative description also indicates that public nonprofit institutions/organizations such as hospitals are within the intended applicant pool.
What are grant funds intended to pay for?
Because expanded lab testing is expected to be provided at no charge through a government laboratory, the grant dollars are described as being intended to support coordination, research, analysis, interpretation, and translation of findings into early warning signals rather than paying for new specimen collection or building laboratory capacity.
Is new specimen collection required or funded?
The project is explicitly designed to avoid paying for new specimen collection by re-using specimens that were already collected and analyzed under routine protocols. The emphasis is on leveraging existing samples before they are discarded.
What makes the intended results "geographically and demographically sensitive"?
The opportunity emphasizes producing an actionable picture of drug exposure patterns that reflects differences across local areas and subpopulations. The project is framed around detecting regionally variable and rapidly changing substances, including novel synthetic drugs.
Browse more opportunities from the same category: Science and Technology and other Research and Development
Next opportunity: 3D Visualization utilizing a Dynamic Environment
Previous opportunity: Develop Monitoring Protocols to Evaluate Vulnerabilities of Traditional Architecture Resources/Sites in the Arid West
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for ONDCP DEW 2017
Applicants also applied for:
Applicants who have applied for this opportunity (ONDCP DEW 2017) also looked into and applied for these:
| Funding Opportunity |
|---|
| Time-Varying Nuclear Decay Parameters Apply for CRANBAA18 001 Funding Number: CRANBAA18 001 Agency: Department of Defense, NSWC - CRANE Category: Science and Technology and other Research and Development Funding Amount: $80,000 |
| Development of a Web-based System to Geoenable NER Parks and Programs Apply for NPS 17 NERO 0207 Funding Number: NPS 17 NERO 0207 Agency: Department of the Interior, National Park Service Category: Science and Technology and other Research and Development Funding Amount: $35,000 |
| Cooperative Ecosystems Studies Units Apply for F17AS00450 Funding Number: F17AS00450 Agency: Department of the Interior, Fish and Wildlife Service Category: Science and Technology and other Research and Development Funding Amount: $25,000 |
| Cooperative Ecosystems Studies Unit Apply for F17AS00449 Funding Number: F17AS00449 Agency: Department of the Interior, Fish and Wildlife Service Category: Science and Technology and other Research and Development Funding Amount: $25,000 |
| SILICON CARBIDE HIGH-VOLTAGE POWER SWITCHES Apply for W911NF17S0003 SCHVPS Funding Number: W911NF17S0003 SCHVPS Agency: Department of Defense, Dept of the Army -- Materiel Command Category: Science and Technology and other Research and Development Funding Amount: $2,000,000 |
| SILICON CARBIDE ADVANCED PACKAGING OF POWER SEMICONDUCTORS II Apply for W911NF17S0003 SCAPOPS Funding Number: W911NF17S0003 SCAPOPS Agency: Department of Defense, Dept of the Army -- Materiel Command Category: Science and Technology and other Research and Development Funding Amount: $2,500,000 |
| Mine Drainage Technology Initiative (MDTI) Cooperative Agreement Program Apply for S17AS00005 Funding Number: S17AS00005 Agency: Department of the Interior, Office of Surface Mining Category: Science and Technology and other Research and Development Funding Amount: $200,000 |
| Create Thematic Web Exhibits Highlighting Civil Rights Movement using NCR Museum Collections Apply for P17AS00794 Funding Number: P17AS00794 Agency: Department of the Interior, National Park Service Category: Science and Technology and other Research and Development Funding Amount: $51,600 |
| National Water Trail Conceptual Plan Apply for P17AS00804 Funding Number: P17AS00804 Agency: Department of the Interior, National Park Service Category: Science and Technology and other Research and Development Funding Amount: $46,000 |
| Migratory Bird Monitoring, Assessment and Conservation Apply for F17AS00453 Funding Number: F17AS00453 Agency: Department of the Interior, Fish and Wildlife Service Category: Science and Technology and other Research and Development Funding Amount: $75,000 |
| STATEMAP - The State Component of the National Cooperative Geologic Mapping Program Apply for G18AS00006 Funding Number: G18AS00006 Agency: Department of the Interior, Geological Survey Category: Science and Technology and other Research and Development Funding Amount: $300,000 |
| Survey to Assess the Status of the Texas Hornshell Freshwater Mussels Apply for F17AS00459 Funding Number: F17AS00459 Agency: Department of the Interior, Fish and Wildlife Service Category: Science and Technology and other Research and Development Funding Amount: $140,000 |
| Cooperative Agreement - Endangered Species Act Apply for F17AS00466 Funding Number: F17AS00466 Agency: Department of the Interior, Fish and Wildlife Service Category: Science and Technology and other Research and Development Funding Amount: $200,000 |
| Collaborative Research in Magnetic Fusion Energy Sciences on Long-Pulse International Stellarator Facilities Apply for DE FOA 0001811 Funding Number: DE FOA 0001811 Agency: Department of Energy - Office of Science, Office of Science Category: Science and Technology and other Research and Development Funding Amount: $600,000 |
| Partnerships for Research and Education in Materials Apply for 17 599 Funding Number: 17 599 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: $700,000 |
| Fish and Wildlife Coordination and Assistance Apply for F17AS00478 Funding Number: F17AS00478 Agency: Department of the Interior, Fish and Wildlife Service Category: Science and Technology and other Research and Development Funding Amount: $128,000 |
| Leading Engineering for America's Prosperity, Health, and Infrastructure Apply for 17 602 Funding Number: 17 602 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: $2,000,000 |
| Dynamically and Controllably Reconfigurable Antennas through Physical Deformation Processes Apply for FOA AFRL AFOSR 2017 0003 Funding Number: FOA AFRL AFOSR 2017 0003 Agency: Department of Defense, Air Force Office of Scientific Research Category: Science and Technology and other Research and Development Funding Amount: $4,800,000 |
| “Development and Deployment of Innovative Asphalt Pavement Technologies” Apply for 693JJ318NF00001 Funding Number: 693JJ318NF00001 Agency: Department of Transportation, DOT Federal Highway Administration Category: Science and Technology and other Research and Development Funding Amount: $3,000,000 |
| MEITNER FOA Apply for DE FOA 0001798 Funding Number: DE FOA 0001798 Agency: Department of Energy, Advanced Research Projects Agency Energy Category: Science and Technology and other Research and Development Funding Amount: $5,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "ONDCP DEW 2017", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.